However, YKL-40 was found useful in the differential diagnostics between FTLD and psychiatric diseases, as higher YKL-40 levels in combination with higher NfL levels and reduced p-tau/tau ratio in the CSF could be used to distinguish FTLD patients from those with a psychiatric disease (Vijverberg et al., 2017). The gene discussed is CHI3L1; the disease is psychiatric disorder.